Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Journal of Cellular Biochemistry|March 20, 2001
Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate glandA Shabsigh, M A Ghafar, A de la Taille, et al.
HIV Medicine|May 18, 2021
Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapyK N Mmasa, K Powis, S Sun, et al.
International Journal of Clinical Practice|June 29, 2010
Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative researchK S Coyne, C C Sexton, Z Kopp, et al.
The Journal of Urology|March 1, 1992
Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancerM C Benson, I S Whang, A Pantuck, et al.
Urology|June 1, 1996
Etiology of voiding dysfunction in men less than 50 years of ageS A Kaplan, E F Ikeguchi, R P Santarosa, et al.
Urology|February 1, 1996
The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator GroupC G Roehrborn, J E Oesterling, S Auerbach, et al.
Urology|July 22, 1998
Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptomsS A Kaplan, R B Reis, A Cologna, et al.
Urology|March 30, 1999
Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunctionS A Kaplan, R B Reis, I J Kohn, et al.
Neurourology and Urodynamics|February 19, 2000
Acute increase in blood flow to the rat bladder subsequent to partial bladder outlet obstructionA Shabsigh, O R Hayek, D Weiner, et al.
The Journal of Urology|November 1, 1993
The titanium intraprostatic stent: the United States experienceS A Kaplan, D C Merrill, W G Mosely, et al.
Pageof 23